ADMA Biologics ADMA Accounts Payable

Accounts Payable at other companies

AbCellera Biologics Inc.ABCL

$12.11M-62.2%

Lifecore Biomedical, Inc.LFCR

$7.53M—

AnaptysBio, Inc.ANAB

$7.52M+22.8%

Absci CorporationABSI

$8.83M+78.4%

Avalo TherapeuticsAVTX

$3.35M+41.5%

Apogee Therapeutics, Inc.APGE

$1.24M-49.4%

FAQ

What is ADMA Biologics's accounts payable?

ADMA Biologics (ADMA) reported accounts payable of $31.72M in Q2 2026.

How has ADMA Biologics's accounts payable changed year-over-year?

ADMA Biologics's accounts payable increased by 6.6% year-over-year, from $29.77M to $31.72M.

What is the long-term trend for ADMA Biologics's accounts payable?

Over 5 years (2020 to 2025), ADMA Biologics's accounts payable has grown at a 15.3% compound annual growth rate (CAGR), from $11.07M to $22.52M.

What does accounts payable mean?

Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.